VCEL

Vericel Corporation provides advanced therapies for the sports medicine and severe burn care markets. The company develops and markets two autologous cell therapy products and one specialty biologic product in the United States. Its offerings focus on repairing injuries and restoring function, primarily serving healthcare providers and patients in need of orthopedic and burn care solutions. Vericel operates in the biotechnology sector and is headquartered in Cambridge, Massachusetts.